AU612720B2 - Pharmaceutical product containing vincristine and peptide - Google Patents

Pharmaceutical product containing vincristine and peptide Download PDF

Info

Publication number
AU612720B2
AU612720B2 AU24906/88A AU2490688A AU612720B2 AU 612720 B2 AU612720 B2 AU 612720B2 AU 24906/88 A AU24906/88 A AU 24906/88A AU 2490688 A AU2490688 A AU 2490688A AU 612720 B2 AU612720 B2 AU 612720B2
Authority
AU
Australia
Prior art keywords
met
salt
peptide
vincristine
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU24906/88A
Other languages
English (en)
Other versions
AU2490688A (en
Inventor
Victor Johannes Nickolson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of AU2490688A publication Critical patent/AU2490688A/en
Application granted granted Critical
Publication of AU612720B2 publication Critical patent/AU612720B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AU24906/88A 1987-11-11 1988-11-08 Pharmaceutical product containing vincristine and peptide Ceased AU612720B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8702688 1987-11-11
NL8702688 1987-11-11

Publications (2)

Publication Number Publication Date
AU2490688A AU2490688A (en) 1989-05-11
AU612720B2 true AU612720B2 (en) 1991-07-18

Family

ID=19850895

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24906/88A Ceased AU612720B2 (en) 1987-11-11 1988-11-08 Pharmaceutical product containing vincristine and peptide

Country Status (13)

Country Link
US (1) US5055449A (enExample)
EP (1) EP0316030B1 (enExample)
JP (1) JPH01163123A (enExample)
KR (1) KR890007752A (enExample)
AT (1) ATE70454T1 (enExample)
AU (1) AU612720B2 (enExample)
DE (1) DE3867039D1 (enExample)
DK (1) DK628388A (enExample)
ES (1) ES2045092T3 (enExample)
GR (1) GR3003930T3 (enExample)
IE (1) IE883296L (enExample)
NZ (1) NZ226915A (enExample)
ZA (1) ZA888335B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4000154A1 (de) * 1990-01-04 1991-07-11 Symbiotec Gmbh Chemotherapeutisches mittel, insbesondere zur behandlung von krebserkrankungen
US5173521A (en) * 1990-06-19 1992-12-22 Mishima Paper Co., Ltd. Absorbent fibrous structure and producing method thereof
AU4063793A (en) * 1992-05-13 1993-12-13 Akzo N.V. Aqueous hexapeptide compositions
US8110829B2 (en) 2007-05-31 2012-02-07 Lg Display Co., Ltd. Array substrate of liquid crystal display and method for fabricating the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.

Also Published As

Publication number Publication date
AU2490688A (en) 1989-05-11
US5055449A (en) 1991-10-08
DE3867039D1 (de) 1992-01-30
EP0316030B1 (en) 1991-12-18
NZ226915A (en) 1990-08-28
DK628388A (da) 1989-05-12
EP0316030A1 (en) 1989-05-17
JPH01163123A (ja) 1989-06-27
ES2045092T3 (es) 1994-01-16
DK628388D0 (da) 1988-11-10
GR3003930T3 (enExample) 1993-03-16
KR890007752A (ko) 1989-07-05
IE883296L (en) 1989-05-11
ATE70454T1 (de) 1992-01-15
ZA888335B (en) 1989-07-26

Similar Documents

Publication Publication Date Title
US4778810A (en) Nasal delivery of caffeine
US20120178695A1 (en) Methods of treating neuropathic pain
RU2008138381A (ru) Режимы дозирования адреналина
RU99100320A (ru) Назальное введение десмопрессина
EP0809512A1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
AU647463B2 (en) A method and a pharmaceutical preparation for treating pain
CN1136916C (zh) 长效注射用混悬液及其制备方法
AU612720B2 (en) Pharmaceutical product containing vincristine and peptide
JPH06508607A (ja) 眼を治療するための方法および製品
US20110195898A1 (en) Treatment of alzheimer's disease and mild cognitive impairment using gnrh-i analogs and one or more of acetylcholinesterase inhibitors and nmda receptor antagonists
EP0669824B1 (en) Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
WO1999059543A1 (en) A pharmaceutical formulation for nasal administration
US6225300B1 (en) TNF receptor and steroid hormone in a combined therapy
AU612169B2 (en) Preparation for preventing or combating complications in diabetes
JPS63258821A (ja) 鼻腔内投与用薬剤組成物
EP0728479A1 (en) Deacetyl moxisylyte in the treatment of acute urinary retention
SU1706624A1 (ru) Способ лечени опиумно-морфинных наркоманий
WO1993015752A1 (en) Anti-neuropathic composition
JPH05508657A (ja) 加速度病に関連する悪心および嘔吐の治療方法
US7012060B1 (en) TNF receptor and steroid hormone in a combined therapy
WO1988004926A1 (en) Nasal delivery of amino acids
RU1803119C (ru) Способ лечени внематочной беременности
CA1326439C (en) Parenteral growth hormone formulations
KR100344330B1 (ko) 지속성주사현탁제
RU2023110696A (ru) СПОСОБ ЛЕЧЕНИЯ IgA-НЕФРОПАТИИ С ИСПОЛЬЗОВАНИЕМ СЛИТОГО БЕЛКА TACI-FC